Skip to main content
Log in

Immunomodulators isolated from microorganisms

  • Review
  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

Microbial products are surveyed that have an immunoregulatory activity, both from the realm of low-molar-mass compounds and from the group of naturally occurring polymers. The data include in most cases the producer organism or source, a brief chemical characteristic and biological activity. Various groups of substances are compared, the drawbacks attendant on their acquisition and application are pointed out and their advantageous properties are specified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AbFC:

antibody-forming cells

ADCC:

antibody-dependent cell mediated cytotoxicity

BCGF:

B-cell growth factor

DOPA:

3,4-dihydroxyphenylalanine

DTH:

delayed-type hypersensitivity

ELISA:

enzyme-linked immunosorbent assay

GvHR:

graft-vs.-host reaction

HIV:

human immunodeficiency virus

Ig:

immunoglobulin

IFN:

interferon

IL-1, IL-2, IL-3:

interleukins 1, 2 and 3

LPS:

lipopolysaccharide

MDP:

muramyl dipeptide

MΦ:

macrophages

NCWS:

Nocardia-cell wall skeleton

NDCM:

Nocardia-delipidated cell mitogen

NK:

natural killers

NWSM:

Nocardia water-soluble mitogen

NWSMP:

Nocardia water-soluble pellet

PWM:

pokeweed mitogen

SRBC:

sheep red blood cells

References

  • Aoyagi T., Tobe H., Kojima F., Hamada M., Takeuchi T., Umezawa H.: Amastatin, an inhibitor of aminopeptidase A, produced by actinomycetes.J. Antibiot. 31, 636–638 (1978a).

    PubMed  CAS  Google Scholar 

  • Aoyagi T., Yamamoto T., Kojiri K., Kojima F., Hamada M., Takeuchi T., Umezawa H.: Forphenicine, an inhibitor of alkaline phosphatase produced by actinomycetes.J. Antibiot. 31, 244–246 (1978b).

    PubMed  CAS  Google Scholar 

  • Azuma I., Taniyama T., Yamawaki M., Sugimura K., Yamamura Y.: Adjuvant and antitumor activities ofNocardia cell-wall skeletons.Gann 67, 733–736 (1976).

    PubMed  CAS  Google Scholar 

  • Barot-Ciorbaru R., Brochier J., Miyawaki T., Pred'homme J.L., Peitt J.F. Bona C., Taniguchi N., Revillard J.P.: Stimulation of human B lymphocytes byNocardia-delipidated cell mitogen and derived fractions fromN. opaca. Structure-activity relationship.J. Immunol. 135, 3277–3283 (1985).

    PubMed  CAS  Google Scholar 

  • Barot-Ciorbaru R., Cornil I., Grand-Perret T., Poupon M.F.: Antimetastatic effect of immunomodulators fromNocardia opaca in mice and rats activation of peritoneal macrophages by these fractions.Cancer Immunol Immunother.25, 111–118 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Barot-Ciorbaru R., Wietzerbin J., Peitt J.F., Chedid L., Falcoff E., Lederer E.: Induction of interferon synthesis in mice by fractions fromNocardia.Infect. Immun. 19, 353–356 (1978).

    PubMed  CAS  Google Scholar 

  • Berger J., Goldberg M.W.: Borrelidin a new antibiotie with high antiborrelia activity and penicillin enhancement properties.J. Clin. Invest. 28, 1046–1051 (1949).

    Article  Google Scholar 

  • Ciorbaru R., Adam A., Peitt J.F., Lederer E., Bona C., Chedid L.: Isolation of mitogenic and adjuvant active fractions from various species ofNocardiae Infect. Immun. 11, 257–264 (1975).

    PubMed  CAS  Google Scholar 

  • Ciorbaru R., Peitt J.F., Lederer E., Zissman E., Bona C., Chedid L.: Presence and subcellular localization of two distinct mitogenic fractions in the cells ofNocardia rubra andNocardia opaca: preparation of soluble mitogenic peptidoglycan fractions.Infect. Immun. 13, 1084 (1976).

    PubMed  CAS  Google Scholar 

  • Dreyfuss M., Harri E., Hofmann H., Kobel H., Pache W., Tscherter H.: Cyclosporin A and C new metabolites fromTrichoderma polysporum (Link exPers.)Rifai.Eur. J. Microbiol. 3, 125–133 (1976).

    Article  CAS  Google Scholar 

  • Gotoh T., Nakahara K., Nishiura T., Hashimoto M., Kinot T., Kuroda Y., Okuhara M., Kohsaka M., Aoki H., Imanaka H.: Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization.J. Antibiot. 35, 1286–1292 (1982).

    PubMed  CAS  Google Scholar 

  • Hatanaka H., Kino T., Miyata S., Inamura N., Kuroda A., Goto T., Tanaka H., Okuhara M.: FR-900520 and FR-900523, novel immunosuppressants isolated from a streptomyces II. Fermentation, isolation and physico-chemical and biological characteristics.J. Antibiot. 41, 1592–1601 (1988).

    PubMed  CAS  Google Scholar 

  • Hofman, J.: Bacterial endotoxins, pp. 655–682 inHandbook of Toxinology (W.T. Shier, D. Mebs, Eds). Marcel Dekker, New York 1990.

    Google Scholar 

  • Hofman J., Pospíšil M., Mára M., Hříbalová V.: Phenol-water extracts of gram-positiveListeria monocytogenes and gram-negativeSalmonella typhimurium. Comparison of biological activities.Folia Microbiol. 30, 231–236 (1985).

    CAS  Google Scholar 

  • Hong K., Kinoshita T., Miyazaki W., Izawa T., Inoue K.: An anticomplementary agent, K-7 monocarboxylic acid: Its site and mechanism of inhibition of the complement activation cascade.J. Immunol. 122, 2418–2423 (1979).

    PubMed  CAS  Google Scholar 

  • Ishizuka M., Sato J., Sugiyama Y., Takeuchi T., Umezawa H.: Mitogenic effect of testation of lymphocytes.J. Antibiot. 33, 653–662 (1980).

    PubMed  CAS  Google Scholar 

  • Ishizuka M., Masuda T., Kanbayashi N., Watanabe Y., Matsuzaki M., Sawazaki Y., Ohkura A., Takeuchi T., Umezawa H.: Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections.J. Antibiot. 35, 1049–1054 (1982).

    PubMed  CAS  Google Scholar 

  • Ishizuka M., Takeuchi T., Masuda T., Fukusawa S., Umezawa H.: Enhancement of immune responses and possible inhibition of suppressor cells by aclacinomycin. A.J. Antibiot. 34, 331–340 (1981).

    PubMed  CAS  Google Scholar 

  • Ivanitskaya L.P., Oparina O.N., Stekhanova T.N., Navashin S.M.: Low molecular immunomodifiers of natural origin.Antibiotiki 30, 131–138 (1985).

    CAS  Google Scholar 

  • Iwami M., Nakayama O., Terano H., Koshaka M., Oaki H., Imanaka H.: A new immunomodulator, FR-900494: Taxonomy, fermentation, isolation and physico-chemical and biological characteristics.J. Antibiot. 40, 612–622 (1987).

    PubMed  CAS  Google Scholar 

  • Izumi S., Ueda H., Okuhara M., Aoki H., Yamamura Y.: Effect ofNocardia rubra cell wall skeleton on murine interferon productionin vitro.Cancer Res.,46, 1960–1969 (1986).

    PubMed  CAS  Google Scholar 

  • Kaneko I., Kamoshida K., Takahashi S.: Complestatin, a potent anti-complement substance produced byStreptomyces lavendulae. I. Fermentation, isolation and biological characterization.J. Antibiot. 42, 236–241 (1989).

    PubMed  CAS  Google Scholar 

  • Kawai Y., Nakahara K., Gotoh T., Uchida I., Tanaka H., Imanaka H.: Studies on a new immunoactive peptide, FK-156 III. Structure elucidation.J. Antibiot. 35, 1293–1299 (1982).

    PubMed  CAS  Google Scholar 

  • Kayakiri H., Takase S., Shibata T., Okamoto M., Terano H. Hashimoto M.: Structure of kifunensine, a new immunomodulator isolater from an actinomycete.J. Org. Chem. 54, 4015–4016 (1989).

    Article  CAS  Google Scholar 

  • Keller-Schierlein N.: Stoffwechselprodukte von Mikroorganismen. 55. Über die Konstitution des Borrelidins.Helv. Chim. Acta 50, 731–753 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Keller-Schierlein W., Wuthier D., Drantz H.: (3S, 8E)-1,3-dihydroxy-8-decen-5-one, ein Stoffwechselprodukt vonStreptomyces fimbriatus (Millard und Bur 1926).Helv. Chim. Acta 66, 1253–1261 (1983).

    Article  CAS  Google Scholar 

  • Khurnova L.M., Ivanitskaya L.P.: Low-molecular immunomodulators from microorganisms.Antibiotiki 34, 786–792 (1989).

    CAS  Google Scholar 

  • Kinashi H., Someno K., Sakaguchi K., Higashijima T., Miyazawa T.: Structure of concanamycin A.Tetrahedron Lett. 22, 3861–3864 (1981).

    Article  CAS  Google Scholar 

  • Kinashi H., Sakaguchi K.: Structures of concanamycins B and C.J Antibiot. 35, 1618–1620 (1982).

    PubMed  CAS  Google Scholar 

  • Kinashi H., Someno K., Sakaguchi K.: An antimitogenic agent of mouse lymphocytes produced by a streptomycete S-45.Abstr. Papers Ann. Meet. Agric. Chem. Soc. Japan, p. 515, Fukuoka 1980.

  • Kino T., Hatanaka H., Hashimoto M., Nishiyama M., Goto T., Okuhara M., Kohsaka M., Aoki H., Imanaka H.: FK-506, a novel immunosuppressant isolated from a streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.J. Antibot. 40, 1249–1255 (1987).

    CAS  Google Scholar 

  • Koyama S., Ozaki A., Iwasaki Y., Sakita T., Osuga T., Watanabe A., Suzuki M., Kawasaki T., Soma T., Tabuchi T., Nakayama M., Koizumi S., Yokoyama K., Uchida T., Orii K., Tanaka T.: Randomized controlled study of post-operative adjuvant immunochemotherapy withNocardia rubra cell wall skeleton (N-CWS) and Tegafur for gastric carcinoma.Cancer Immunol. Immunother. 22, 148–154 (1986).

    Article  PubMed  CAS  Google Scholar 

  • Lüderitz O., Freudenberg M.A., Galanos C., Lehmann V., Rietschel E.T., Shaw D.H.: Lipopolysaccharides of gram-negative bacteria.Curr. Topics Membr. Transport 17, 79–151 (1982).

    Google Scholar 

  • Mine Y., Yokota Y., Fukada S., Nishida M., Goto S., Kuwahara S.: Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.J. Antibiot. 36, 1045–1050 (1983).

    PubMed  CAS  Google Scholar 

  • Mizutani S., Odai H., Masuda T., Lijima M., Osono M., Hamada M., Naganawa H., Ishizuka M., Takeuchi T.: Biological activities of IC201 (3S,8E)-1,3-dihydroxy-8-decen-5-one), a low molecular weight immunomodulator produced byStreptomyces.J. Antibiot. 42, 952–959 (1989).

    PubMed  CAS  Google Scholar 

  • Nakamura A., Nagai K., Ando K., Tamura G.: Selective suppression by prodigiosin of the mitogenic response of murine splenocytes.J. Antibiot. 39, 1155–1159 (1986).

    PubMed  CAS  Google Scholar 

  • Nakamura A., Nagai K., Suzuki S., Ando K., Tamura G.: A novel method of screening for immunomodulating substances, establishment of an assay system and its application to culture broth of microorganisms.J. Antibiot. 39, 1148–1154 (1986).

    PubMed  CAS  Google Scholar 

  • Nemoto K., Hayashi M., Sugawara Y., Abe F., Takita T., Takeuchi T.: Effects of deoxyspergualin on hematopoiesis: Studies on murine hematopoietic progenitor cell and peripheral blood cell levels.J. Antibiot. 42, 312–316 (1989).

    PubMed  CAS  Google Scholar 

  • Ohno R., Nakamura H., Kodera Y., Ezaki K., Yokomaku S., Oguma S., Kubota Y., Shibata H., Ogawa N., Masaoka T., Yamada K.: Randomized controlled study of chemoimmunothezapy of acute myelogenous leukemia (AML) in adults withNocardia rubra cell-wall skeleton and irradiated allogenic AML cells.Cancer 57, 1483–1488 (1986).

    Article  PubMed  CAS  Google Scholar 

  • Okura A., Nakadaira M., Naito K., Ishizuka M., Takeuchi T., Umezawa H.: Effect of forphenicinol on γ-interferon production in mice sensitized with BCG.J. Antibiot. 39, 569–574 (1986).

    PubMed  CAS  Google Scholar 

  • Ratliff D.A., Carr N., Cochrane J.P.S.: Rectal stricture due to actinomycosis.Brit. J. Surg. 73, 589–590 (1986).

    Article  PubMed  CAS  Google Scholar 

  • Ryffel B.: Experimental toxicological studies with cyclosporin A pp. 45–75 inCyclosporin A. Proc. Internat. Conf. Cyclosporin A (D.J.G. White, Ed.), Elsevier Biomedical Press, Amsterdam 1982.

    Google Scholar 

  • Sakatani M., Ogura T., Masuno T., Kishimoto S., Yamamura Y.: Effect ofNocardia rubra cell wall skeleton on augmentation of cytotoxicity function in human pleural macrophages.Cancer Immunol. Immunother. 25, 119–125 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Sato H., Ochiai T., Sato H., Hayashi R., Watanabe K., Asano T., Isono K., Tanaka T.: Result of randomized clinical trial of immunotherapy withNocardia rubra-CWS on postoperable gastric cancer patients.J. Japan Surg. Soc. 83, 635–648 (1982).

    Google Scholar 

  • Shibuya K., Hayashi E., Abe F., Takahashi K., Horinishi H., Ishizuka M., Takeuchi T., Imezawa H.: Enhancement of the interleukin-1 and interleukin-2 releases by ubenimex.J. Antibiot. 40, 363–369 (1987).

    PubMed  CAS  Google Scholar 

  • Sone, S., Fidler I.J.: In situactivation of tumoricidal properties in rat alveolar macrophages and rejection of experimental lung metastases by intravenous injections ofNocardia rubra cell wall skeleton.Cancer Immunol. Immunother. 12, 203–209 (1982).

    Article  Google Scholar 

  • Šterzl J., Řeháček Z., Cudlín J.: Regulation of immune response by ergot alkaloids.J. Czech. Med. 10, 90–98 (1987).

    Google Scholar 

  • Takeuchi T., Iinuma H., Kunimoto S., Masuda T., Ishizuka M., Takeuchi M., Hamada M., Naganawa H., Kondo S., Umezawa H.: A new antitumor antibiotic, spergualin: Isolation and antitumor activity.J. Antibiot. 34, 1619–1621 (1981).

    PubMed  CAS  Google Scholar 

  • Takeuchi T., Takahashi S., Iinuma H., Umezawa H.: Diketocoriolin B, an, active derivative of coriolin B produced byCoriolus consors.J. Antibiot. 24, 631–635 (1971).

    PubMed  CAS  Google Scholar 

  • Tanaka H., Kuroda A., Marusawa H., Hashimoto M., Hatanaka H., Kino T., Goto T., Okuhara M.: Physicochemical properties of FK-506, a novel immunosuppressant isolated fromStreptomyces tsukubaensis.Transplant. Proc. 19, 11–16 (1987).

    PubMed  CAS  Google Scholar 

  • Tlaskalová-Hogenová H., Bártová J., Mrklas L., Mančal P., Broukal Z., Barot-Ciorbaru R., Novák M., Hanikýřová M.: Stimulation of human blood lymphocyte by different polyclonal B cell activators of bacterial and plant origin: Production of IgM, IgG and IgA estimated by the ELISA method.Folia Microbiol. 30, 258–266 (1985).

    Google Scholar 

  • Umezawa H., Aoyagi T., Hazato T., Uotani K., Hamada M., Takeuchi T.: Esterastin, an inhibitor of esterase, produced by actinomycetes.J. Antibiot. 31, 639–641 (1978).

    PubMed  CAS  Google Scholar 

  • Umezawa H., Aoyagi T., Suda H., Hamada M., Takeuchi T.: Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.J. Antibiot. 29, 97–99 (1976).

    PubMed  CAS  Google Scholar 

  • Umezawa H., Aoyagi T., Uotani K., Hamada M., Takeuchi T., Takanashi S.: Ebelactone, an inhibitor of esterase, produced by actinomycetes.J. Antibiot. 33, 1594–1598 (1980).

    PubMed  CAS  Google Scholar 

  • Umezawa H., Kondo S., Iinuma H., Kunimoto S., Ikeda Y., Iwasawa H., Ikeda D., Takeuchi T.: Structure of an antitumor antibiotic, spergualin.J. Antibiot. 34, 1622–1624 (1981).

    PubMed  CAS  Google Scholar 

  • Westley J.W., Liu C.M., Sello L.H., Evans A.H., Troupe N., Blount J.F., Chiu A.M., Todaro L.J., Miller P.A.: The structure and absolute configuration of the 18-membered macrolide lactone antibiotic X-4357B (concanamycin A).J. Antibiot. 37, 1738–1740 (1984).

    PubMed  CAS  Google Scholar 

  • Yamaguchi T., Ichimaru M., Kohno F., Takatsuki K., Kishimoto S., Araki K., Tomosue H., Takada M., Matsumoto M., Yuki K., Nishioka K., Hashimoto S., Ogawa N.: Adjuvant activity ofNocardia cell-wall skeleton on maintenance chemotherapy and acute non-lymphatic leukemia.Acta Haematol. Japan 46, 1096–1098 (1983).

    Google Scholar 

  • Yamakido M., Yanagida J., Ishioka S., Matsuzaka S., Hozawa S., Takaishi M., Akiyama M., Nishimoto Y.: Effects ofNocardia rubra cell wall skeleton on lymphocyte subsets in former poison gas factory workers.Japan J. Cancer Res. (Gann) 76, 1091–1098 (1985).

    CAS  Google Scholar 

  • Yamakido M., Yanagida J., Ishioka S., Matsuzaka S., Hozawa S., Takaishi M., Akiyama M., Nishimoto Y.: Effects ofNocardia rubra cell wall skeleton on interleukin 2 production and lymphocyte proliferation in former poison gas factors workers.Japan. J. Cancer. Res. (Gann) 77, 406–412 (1986).

    CAS  Google Scholar 

  • Yamamura Y., Ogura T., Sakatani M., Hirao F., Kishimoto S., Fukuoka M., Takada M., Kawahara M., Furuse K., Kuwahara O., Ikegami H., Ogawa N.: Randomized controlled study of adjuvant immunotherapy withNocardia rubra cell wall skeleton for inoperable long cancer.Cancer Res. 43, 5575–5579 (1983).

    PubMed  CAS  Google Scholar 

  • Yokota Y., Mine Y., Wakai Y., Watanabe Y., Nishida M., Gota S., Kawahara S.: Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.J. Antibiot. 36, 1051–1058 (1983).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated by K. Sigler

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaněk, Z., Matějů, J. & Čurdová, E. Immunomodulators isolated from microorganisms. Folia Microbiol 36, 99–111 (1991). https://doi.org/10.1007/BF02814487

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02814487

Keywords

Navigation